When comparing trial outcomes using standard network meta-analysis (NMA), the assumption is that populations in different trials do not differ in any characteristics that may impact the treatment effect... read more →
Correlates of protection in determining vaccine efficacy is a topic of particular interest, given the current COVID-19 climate and the spotlight on vaccine development. Here at Quantics, we have... read more →
A clinical trial is often designed to demonstrate that a new treatment is performing better than the currently available treatment. To do this, one must show that there is... read more →
Bioassay simulation can be used during assay development maintenance to supplement and complement the information gained from lab experiments. Bioassay simulation assumes that the available real data is a... read more →
COVID-19 disruption of clinical trials is likely to result in missing data, disrupted timelines, and perhaps patient population changes. We thought we would dedicate a blog post to the... read more →